Section 32

Section 32 is a venture capital firm founded by Bill Maris, the former CEO of Google Ventures. Established in 2017, the firm is based in San Diego, California, and manages approximately $1 billion in assets. Section 32 focuses on early and growth-stage investments across technology, biotechnology, healthcare, and life sciences sectors. The firm has raised multiple funds, including a $160 million inaugural fund and a $200 million second fund. Section 32's portfolio includes notable companies such as Coinbase, CrowdStrike, Thrive Earlier Detection, and Vir Biotechnology. The firm emphasizes investing in transformative technologies that can make a significant impact on the healthcare and tech industries. The team at Section 32 includes several seasoned professionals, such as Michael Pellini, former CEO of Foundation Medicine, who joined as a Managing Partner, and Steve Kafka, former President and COO of Foundation Medicine, who also serves as a Managing Partner. The firm prides itself on a strategic approach that combines deep industry expertise with a commitment to fostering innovation and growth in its portfolio companies.